We thank Annemarie Black, Cairns Hospital Pharmacy, who provided valuable advice during the manuscript’s revision.
Centers for Disease Control, 2016. Resources for Health Professionals. Available at: https://www.cdc.gov/parasites/strongyloides/health_professionals/index.html. Accessed August 30, 2018.
Schär F, Trostdorf U, Giardina F, Khieu V, Muth S, Marti H, Vounatsou P, Odermatt P, 2013. Strongyloides stercoralis: global distribution and risk factors. PLoS Negl Trop Dis 7: e2288.
Paltridge M, Traves A, 2018. The health effects of strongyloidiasis on pregnant women and children: a systematic literature review. Trop Med Infect Dis 3: 50.
Fisher D, McCarry F, Currie B, 1993. Strongyloidiasis in the Northern Territory. Under-recognised and under-treated? Med J Aust 159: 88–90.
Flannery G, White N, Flannery G, White N, 1993. Immunological Parameters in Northeast Arnhem Land Aborigines: Consequences of Changing Settlement Patterns and Lifestyles. Urban Ecology and Health in the Third World. Cambridge, UK: Cambridge University Press, 202–220.
Kearns TM 2017. Strongyloides seroprevalence before and after an ivermectin mass drug administration in a remote Australian aboriginal community. PLoS Negl Trop Dis 11: e0005607.
Meloni BP, Thompson RC, Hopkins RM, Reynoldson JA, Gracey M, 1993. The prevalence of giardia and other intestinal parasites in children, dogs and cats from aboriginal communities in the Kimberley. Med J Aust 158: 157–159.
Shield J, Aland K, Kearns T, Gongdjalk G, Holt D, Currie B, Prociv P, 2015. Intestinal parasites of children and adults in a remote aboriginal community of the Northern Territory, Australia, 1994–1996. Western Pac Surveill Response J 6: 44–51.
Furuya-Kanamori L, Yakob L, Riley TV, Paterson DL, Baker P, McKenzie SJ, Robson J, Clements AC, 2016. Community-acquired Clostridium difficile infection, Queensland, Australia. Emerg Infect Dis 22: 1659–1661.
Hollingworth SA, Chan R, Pham J, Shi S, Ford PJ, 2017. Prescribing patterns of analgesics and other medicines by dental practitioners in Australia from 2001 to 2012. Community Dent Oral Epidemiol 45: 303–309.
Therapeutic Goods Administration, 2013. Product Information for AusPAR Stromectol Ivermectin Merck Sharp Dohme (Australia). Canberra, Australia: Department of Health, Therapeutic Goods Administration.
Therapeutic Guidelines, 2014. Strongyloidiasis. Available at: https://tgldcdp-tg-org-au./viewTopic?topicfile=gastrointestinal-helminths&guidelineName=Antibiotic#toc_d1e204. Accessed December 1, 2018.
Davis JS 2003. Prevention of opportunistic infections in immunosuppressed patients in the tropical Top End of the Northern Territory of Australia. Commun Dis Intell 27: 7.
Hempenstall A, Smith S, Hanson J, 2019. Leprosy in Far North Queensland: almost gone, but not to be forgotten. Med J Aust 211: 182–183.
Holland C, 2018. A Ten-Year Review the Closing the Gap Strategy and Recommendations for Reset: The Close the Gap Campaign Steering Committee. Sydney, NSW, Australia: Australian Human Rights Committee.
Australian Bureau of Statistics, 2012. Regional Population Growth, Australia. Canberra, Australia: Australian Bureau of Statistics, Australian Government.
Hall N, Barbosa M, Currie D, Dean A, Head S, Hill P, Naylor S, Reid S, Selvey L, Willis J, 2017. Water, Sanitation and Hygiene in Remote Indigenous Australian Communities: A Scan of Priorities. Queensland TUo, ed. Global Change Institute discussion paper: Water for equity and wellbeing series. Brisbane: University of Queensland.
Australian Institute of Health and Welfare, 2015. The Health and Welfare of Australia’s Aboriginal and Torres Strait Islander Peoples. Canberra, Australia: Australian Institute of Health and Welfare.
Olsen A, van Lieshout L, Marti H, Polderman T, Polman K, Steinmann P, Stothard R, Thybo S, Verweij JJ, Magnussen P, 2009. Strongyloidiasis – the most neglected of the neglected tropical diseases? Trans R Soc Trop Med Hyg 103: 967–972.
Senephansiri P, Laummaunwai P, Laymanivong S, Boonmar T, 2017. Status and risk factors of Strongyloides stercoralis infection in rural communities of Xayaburi province, Lao PDR. Korean J Parasitol 55: 569–573.
Hays R, Esterman A, McDermott R, 2017. Control of chronic Strongyloides stercoralis infection in an endemic community may be possible by pharmacological means alone: results of a three-year cohort study. PLoS Negl Trop Dis 11: e0005825.
Paradies P, Iarussi F, Sasanelli M, Capogna A, Lia RP, Zucca D, Greco B, Cantacessi C, Otranto D, 2017. Occurrence of strongyloidiasis in privately owned and sheltered dogs: clinical presentation and treatment outcome. Parasit Vectors 10: 345.
Mayer-Coverdale KJ, Crowe A, Smith P, Baird WR, 2017. Trends in Strongyloides stercoralis faecal larvae detections in the Northern Territory, Australia: 2002 to 2012. Trop Med Infect Dis 2: E18.
Therapeutic Guidelines, 2014. Immunosuppressed patients: prevention of other infections. Prevention of infection: immunosuppressed patients. West Melbourne, Victoria, Australia: Therapeutic Guidelines Limited.
Smith S, Russell D, Horne P, Hanson J, 2019. HTLV-1 is rare in Far North Queensland despite a significant burden of classically associated diseases. Pathology 51: 91–94.